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Abstract
Background: Few reports have examined tissue factor (TF) and autophagy expression in chronic pulmonary
thromboembolic hypertension (CTEPH) animal models. Objectives: To investigate the role of tissue factor (TF),
autophagy and their interactions during chronic thromboembolic pulmonary hypertension (CTEPH) pathogenesis in
a rat model.
Methods: Autologous blood clots were repeatedly injected into the left jugular vein of rats with injecting
endogenous fibrinolysis inhibitor tranexamic acid (TXA). Mean pulmonary arterial pressure (mPAP), histopathology
and TF, Beclin-1 and microtubule-associated protein 1 light chain (LC3) expression levels were detected.
Results: The mPAP and vessel wall area/total area (WA/TA) ratio in the experiment group increased significantly
(P < 0.05). TF mRNA and protein expression levels in the experiment group increased significantly (P < 0.05). Beclin-1
and LC3B mRNA and protein expression levels were lower in the experiment group (P < 0.05). The mPAP had a
positive correlation with WA/TA ratio (r = 0.955, P < 0.05). Beclin-1 and LC3B protein expression had a negative
correlation with the WA/TA ratio (r = -0.963, P < 0.05, r = -0.965, P < 0.05, respectively). TF protein expression had a
negative correlation with both Beclin-1 and LC3B protein expression (r = -0.995, P <0.05, r = -0972, P < 0.05,
respectively).
Conclusions: A rat model of CTEPH can be established by repeatedly introducing autologous blood clots into the
pulmonary artery with injecting TXA. TF and autophagy may play a key role during CTEPH pathogenesis, especially
in vascular remodeling.
Abbreviations: CPE, Chronic pulmonary embolism; CTEPH, Chronic pulmonary thromboembolic hypertension; DAB,
3,3′-diaminobenzidine; DVT, Deep vein thrombosis; HE, Hematoxylin and eosin; LC3, Microtubule-associated protein
1 light chain; MAPK, Mitogen-activated protein kinase; mPAP, Mean pulmonary arterial pressure; PAECs, Pulmonary
artery endothelial cells; PE, Pulmonary embolism; PTE, Pulmonary thromboembolism; PVC, Polyvinyl chloride
catheter; TF, Tissue factor; TXA, Tranexamic acid; WA/TA, Vessel wall area/total area
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Background
Pulmonary embolism (PE) refers to the obstruction of the
pulmonary artery or one of its branches by an embolus
(e.g., thrombus, tumor, air, or fat) originating elsewhere in
the body. The most common pulmonary embolus is
thrombus, also known as pulmonary thromboembolism
(PTE). Chronic thromboembolic pulmonary hypertension
(CTEPH) is regarded as a late sequela of PTE [1]. Several
animal models of PTE have been developed to further elu-
cidate the pathogenesis and pathophysiological changes of
PTE [2]. A chronic pulmonary embolism (CPE) animal
model can be induced by the injection of polidocanol foam
into the peripheral veins of rabbits [3]. However, few re-
ports have examined CTEPH animal models because of
their robust fibrinolytic system. As in previous studies, we
have successfully established a chronic PTE animal model
for the study of lung ischemia reperfusion injury using tran-
examic acid (TXA) that inhibits endogenous fibrinolysis
[4]. Moreover, since large animals such as dogs are more
expensive and prohibitive in terms of large-scale experi-
ments, we have successfully established a rat model of
CTEPH.
Thrombotic factor tissue factor (TF) is a membrane-
bound protein initiation factor of the extrinsic coagula-
tion pathway. The interaction between TF and factor
VIIa (FVIIa) promotes the conversion of fibrinogen (Fg)
into fibrin (Fb) [5]. A number of studies have shown that
upregulated TF expression plays a critical role in the
process of thrombosis [6, 7]. However, few reports have
examined TF expression in an animal CTEPH model.
Autophagy is an evolutionarily conserved process for the
turnover of misfolded or aggregated cytoplasmic proteins,
damaged organelles, and intracellular pathogens utilizing a
lysosome-dependent degradation pathway [8]. Beclin-1 is a
key component of autophagy and microtubule-associated
protein 1 light chain (LC3) is a good indicator of autophagy
[9]; however, the extent of their involvement in the occur-
rence and progression of CTEPH vascular endothelial
lesions through the regulation of autophagic capacity re-
mains unclear [8].
Therefore, in this study, we examined TF, Beclin-1 and
LC3 expression in the CTEPH rat model and deter-
mined their role and interactions during CTEPH throm-
bosis and remodeling of the pulmonary vasculature.
Methods
Animal preparation and grouping
All experimental and animal care protocols were ap-
proved by the animal ethics committee of the Fujian
Medical University Institutional Animal Care (SYXK
2012-0001) and Use Committee and the Guide for the
Care and Use of Laboratory Animals (NIH, Bethesda,
MD, USA). Ninety 2–3 month old healthy male Sprague
Dawley (SD) rats (weighing 250–300 g) were provided
by the Experimental Animal Center of Fujian Medical
University (China). The rats were randomly divided into
a sham operation group (n = 45) and experimental group
(n = 45). The experimental group rats received an add-
itional injection of autologous blood clots 4 days following
the first injection; the procedures in the sham operation
group were the same as in the experimental group except
that the rats were injected with 0.9 % NaCl instead of
autologous blood clots. The rats were further divided into
three subgroups according to the time of observation: 1-
week subgroup (n = 15), 2-week subgroup (n = 15), and 4-
week subgroup (n = 15). The animals were kept in an
isolated location at 20–24 °C and 65–70 % humidity and
their activity was restricted approximately one week prior
to the operation in order to mimic blood stasis in the clin-
ical practice. All rats had free access to food and water.
Autologous blood clot preparation
Blood was collected from the orbital vein using a capillary
glass tube (inner diameter, 1 mm) and placed in sterilized
petri dishes at room temperature for 24 h. Clots were rush
out with normal saline from capillary glass tubes and then
trimmed to 3 mm lengths. After that, clots were aspirated
into a syringe with 2 ml normal saline containing TXA
(200 mg/kg/rat) and then flipped into a catheter con-
nected to a 7 F needle for later use.
Animal model induction
The rats were fixed to the operating table following
anesthesia with an intraperitoneal injection of 10 %
chloral hydrate (0.3 g/kg) and the left external jugular
vein was subsequently separated under sterile condi-
tions. Next, the previously prepared clots were injected
into the left jugular vein of the rat. Rats in the sham op-
eration group were administered with 2 ml of 0.9 %
NaCl via the left jugular vein. Injections were repeated
in both the experimental and sham operation group
4 days following the first injection. Endogenous fibrin-
olysis was inhibited during the experiment with an intra-
peritoneal injection of TXA (200 mg/kg, 1 time/day
until rats were killed). After the injection, the animals
were returned to their habitat. Enteric-coated indometh-
acin tablets (0.5 mg/kg, 3 times/ day for 3 days) were
provided for relieving pain per oral. Prophylactic penicil-
lin (10,000 U/kg/day, for 3 days) was also provided to
prevent infection.
Detection of pulmonary arterial pressure in rats
The rats were injected intraperitoneally with 10 % chloral
hydrate (0.3 g/kg) and fixed in a supine position at either 1,
2, or 4 weeks following the second injection. The right
external jugular vein was isolated and a PE-50 polyvinyl
chloride (PVC) catheter connected to a pressure transducer
and the biological signal acquisition system was slowly
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inserted. Catheter position was determined in accordance
with changes in the pressure curve waveform and the cath-
eter was extended into the superior vena cava, right atrium,
right ventricle, and pulmonary arteries (Fig. 1).
Histopathology
Lung tissues were selectively fixed with 10 % formaldehyde
for 24 h, embedded in paraffin, and stained with
hematoxylin and eosin (HE). The pathological changes in
the pulmonary arteries were observed using an optical
microscope (Leica DMI3000M, Germany) and the pulmon-
ary arterial (50–100 μm) vessel wall area/total area (WA/
TA) ratio was calculated using Images-Pro Plus (Mass
precision instrument equipment co., LTD, Shenzhen,
China) to evaluate the level of pulmonary arterial
remodeling.
Plasma TF concentrations
TF antigen concentration and activity in the plasma at 1,
2, and 4 weeks were determined using an enzyme-linked
immunosorbent assay (ELISA) kit (Bluegene Biotech
CO., LTD, Shanghai, China) and a Rat TF Chromogenic
activity assay kit (Abcam (Shanghai) trading co., LTD,
Shanghai, China), respectively, according to the manu-
facturer’s instructions.
Immunohistochemistry
Rat pulmonary artery sections were deparaffinized and
rehydrated using an alcohol gradient. Following blocking
and antigen retrieval, sections were incubated with rabbit
anti-rat TF, Beclin-1, and LC3B polyclonal antibodies (at
1:50, 1:150, 1:150, respectively; Abcam (Shanghai) trading
co., LTD, Shanghai, China). Next, the sections were treated
with the Biotin-Streptavidin Horseradish Peroxidase (HRP)
Detection System (ZSGB-BIO, Shanghai, China) according
to the manufacturer’s instructions. Additional lung speci-
mens incubated with 1 % bovine serum albumin (BSA)
served as the negative controls. Immunoreactivity was visu-
alized using 3,3′- diaminobenzidine (DAB). The primary
and secondary antibodies were omitted as a negative con-
trol for every group of slides.
RT-PCR
RNA was extracted from the pulmonary artery tissue sam-
ples with the Trizol reagent (Invitrogen, Carlsbad, CA,
USA) and the purity of the RNA was analyzed using spec-
trophotometer (MACY (China) INSTRUMENTS INC,
Shanghai, China). Reverse transcription was performed in
accordance with the manufacturer’s instructions of First
Strand cDNA Synthesis Kit (Sangon Biotech Co., Ltd,
Shanghai, China).
Primer pairs were designed for TF, Beclin-1, LC3B, and
β-actin (internal control) using their DNA sequences
(Sangon Biotech Co., Ltd, Shanghai, China). TF forward:
5′-AGA TGG AGG TGG AGA TGT GG-3′ and TF re-
verse: 5′-AAC AGC AGG TCT TTC CCA AG-3′; Beclin-
1 forward 5′-TGT TTG GAG ATG TTG GAG CA-3′
and Beclin-1 reverse: 5′-ATG GAA GGT CGC ATT GAA
GA-3′; LC3B forward: 5′-GTC TTT GTG GGT TGG
ACC TC-3′ and LC3B reverse: 5′-TGG ATT TCT TCA
GTT GCT TGG-3′; β-actin forward: 5′-AAC CCT AAG
GCC AAC CGT G-3′ and β-actin reverse: 5′-TGC TCG
AAG TCT AGG GCA AC-3′. Cycling conditions were as
follows: 94 °C denaturation for 5 min; 35 cycles of 94 °C
Fig. 1 Detection of pulmonary arterial pressure in rats. Note: PAP = pulmonary arterial pressure. The curve waveform of pulmonary artery systolic
pressure (black arrow) and diastolic pressure (black arrow head)
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for 30 s, 60 °C for 30 s, and 72 °C for 30 s; and a final
10 min 72 °C extension. The PCR products were subjected
to electrophoresis on a 2 % agarose gel containing 0.5 μg/
ml ethidium bromide and the bands were visualized using
a gel imaging system (HBMA-9600, China). TF, Beclin-1,
and LC3B expression was semi-quantitatively determined
with the imaging software.
Western blot analysis
TF, Beclin-1, and LC3B protein expression was analyzed
by western blot analysis. Protein concentrations were esti-
mated using the Lowry protein assay. Proteins were sepa-
rated by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE). Following blocking with
BSA, the membranes were incubated overnight at 4 °C
with anti-rat TF, anti-Beclin1 and anti-LC3 (1:500, 1:500,
1:1000, respectively; Abcam (Shanghai) trading co., LTD,
Shanghai, China). The membranes were then incubated
with HRP-conjugated secondary antibody (originated from
rabbits) for 2 h at room temperature and the targeted an-
tigens were detected using enhanced chemiluminescence
reagents. The targeted proteins were analyzed using the
Lab-work image analysis software (Gene Company
Limited, Hong Kong, China).
Statistical analysis
SPSS 17.0 (IBM, Armonk, NY, USA) software was used for
statistical analyses. Numerical parameters with normal
Gaussian distribution were expressed as means ± standard
deviation (SD). Parameters measured at various time points
within each group or subgroup were compared by variance
analysis and the Pearson correlation coefficient was used to
determine the correlation between two variables. P values
<0.05 was considered as significant differences.
Results
Pulmonary arterial pressure in the rat model of CTEPH
The pulmonary arterial pressure in the experimental group
and sham operation group were measured; the mean pul-
monary arterial pressure (mPAP) increased gradually subse-
quent to repeated embolization in the 1-, 2-, and 4-week
subgroups in the experimental group. The mPAP was sig-
nificantly increased (P < 0.05) in the 4-week group com-
pared with the 1-week group (Table 1).
Pathological changes in the rat model of CTEPH
No significant changes were apparent in the sham oper-
ation group (Fig. 2a). Macroscopic pathology demonstrated
reddish-brown thrombi adhered to the left lower lobar ar-
tery wall in the 1-week and 2-week subgroups (Fig. 2b) and
dark red pulmonary infarctions in the 4-week subgroup
(Fig. 2c) in the experimental group following repeated
embolization. Histological sections of the pulmonary artery
demonstrated organized tissue covering the surface of the
thrombus and invasive growth into it (Fig. 2d). The pul-
monary artery endothelial cells were closely connected with
the thrombus (Fig. 2e) in the thromboembolic pulmonary
artery and a thickened intima was apparent in the distal
pulmonary artery (Fig. 2f). As shown in Table 1, the WA/
TA ratio in the 1-week, 2-week, and 4-week subgroups in
the experimental group increased significantly (P < 0.05)
compared to the sham operation group.
TF antigen plasma concentration and activity
The plasma TF concentration and activity from different
groups were showed in Table 2. TF concentration in the
1-week, 2-week, and 4-week subgroups in the experimen-
tal group increased significantly compared with the sham
operation group (P < 0.05, respectively). However, no sig-
nificant differences were apparent between the 1-, 2-, and
4-week subgroups in the experimental group (Fig. 3A).
Rat plasma TF activity was higher in the 1-, 2-, and 4-
week subgroups in the experimental group than in the
sham group (P < 0.05, respectively). However, there were
no significant difference between the 1-, 2-, and 4-week
subgroups in the experimental group (Fig. 3B).
TF, Beclin-1, and LC3B antigen expression in the pulmonary
artery following repeated embolization
The TF antigen was visualized with DAB and all brown-
ish red staining were attributed to the TF antigen. In the
sham operation group, TF antigen expression was con-
centrated mainly in the pulmonary artery adventitia and
rarely in the intima (Fig. 4a). In contrast, in the experi-
mental group, TF antigen expression was increased sig-
nificantly in the intima (Fig. 4b-d). Beclin-1 (Fig. 4f-h)
and LC3B (Fig. 4j-l) antigen expression was lower in the
Table 1 Mean pulmonary arterial pressure and vessel wall area/
total area ratio in the rat CTEPH model (x ± SD)
Parameters Subgroup (each n = 15) Sham Experimental group
mPAP (mmHg)
1-week 14.4 ± 2.66 18.97 ± 3.87a
2-week 13.9 ± 2.82 21.89 ± 4.22ad
4-week 14.1 ± 3.12 25.17 ± 4.74ab
WA/TA ratio
1-week 31.2 ± 6.25 46.67 ± 8.50a
2-week 30.1 ± 6.01 49.06 ± 8.82ad
4-week 32.8 ± 6.83 54.03 ± 10.26ac
mPAP mean pulmonary arterial pressure, WA/TA Vessel wall area/total area
aindicated that mPAP and WA/TA in the experimental group compared to sham
operation group (P < 0.05, respectively) in the 1-, 2-, and 4-week subgroups.
bindicated that the mPAP in the 4-week subgroup compared to 1-week subgroup
(P <0.05) and 2-week subgroup (P >0.05) in the experimental group.
cindicated that the WA/TA in the 4-week subgroup compared to 1-week subgroup
(P >0.05) and 2-week subgroup (P >0.05) in the experimental group.
dindicated that the mPAP and WA/TA in the 2-week subgroup compared to
1-week subgroup (P >0.05, respectively) in the experimental group
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experimental group than in the sham operation group
(Fig. 4e, i), especially in the pulmonary arterial intima.
TF, Beclin-1, and LC3B mRNA expression levels in the
pulmonary artery following repeated embolization
TF expression was significantly increased (P < 0.05) in the
1-, 2-, and 4-week subgroups in the experimental group
compared with the sham operation group. Beclin-1 and
LC3B expression was lower (P < 0.05) in the 1-, 2-, and 4-
week subgroups in the experimental group compared with
the sham group, however, there were no significant differ-
ences between the three experimental subgroups (Table 3,
Fig. 5).
TF, Beclin-1, and LC3B protein expression in the pulmonary
artery following repeated embolization
As shown in Fig. 6A, TF, Beclin-1, and LC3B were
expressed in the pulmonary artery of rats in the sham
operation group (a), 1-week subgroup in experimental
group (b), 2-week subgroup in experimental group (c),
and 4-week subgroup in experimental group (d). TF pro-
tein expression in the pulmonary artery was significantly
increased (P < 0.05) in the 1-, 2-, and 4-week subgroups
in the experimental group. However, expression was not
significantly different between the 1-, 2-, and 4-week
subgroups (Fig. 6B). No significant difference were ap-
parent comparing the expression of Beclin-1 and LC3B
in the 1-, 2-, and 4-week subgroups in the experimental
group; however, the expression of both proteins was re-
duced (P < 0.05) (Fig. 6C, D).
Pearson correlation coefficient (r) for WA/TA ratio, mPAP,
TF activity, and TF, Beclin-1, and LC3B protein expression
As shown in Table 4, the mPAP had a positive correlation
with WA/TA ratio (r = 0.955, P < 0.05). TF activity in the
plasma of rats had a positive correlation with the WA/TA
Fig. 2 Pathological changes in the animal model of CTEPH. Note: No significant changes were apparent in the sham group (a). Macroscopic
pathology demonstrated reddish-brown thrombi (black arrow) adhered to the left lower lobar artery wall in the 1-week and 2-week subgroups
(b) and a dark red pulmonary infarction (white arrow) in the 4-week group (c) following repeated embolization. Histological sections of pulmonary
artery demonstrated organized tissue (white arrow) on the surface of the thrombi (black arrow) and invasive growth into it (d, HE, 20×). The pulmonary
artery endothelial cells (white arrow) were closely connected with the thrombus (e, HE, 40×) and the thickened endothelium was present in the distal
pulmonary artery (f, HE, 40×)
Table 2 TF antigen expression and activity in rat plasma from
different groups ðx  SDÞ
Parameters Subgroup (each n = 15) Sham Experimental group
TF antigen
(pg/ml) 1-week 83.24 ± 21.90 170.98 ± 43.06a
2-week 82.45 ± 22.76 205.50 ± 45.71ac
4-week 83.92 ± 24.11 218.97 ± 35.68ab
TF activity
(pM/ml) 1-week 62.62 ± 16.06 103.39 ± 22.05a
2-week 60.15 ± 17.23 119.54 ± 26.70ac
4-week 61.87 ± 16.69 117.12 ± 19.14ab
TF tissue factor
aindicated that TF antigen and activity in the experimental group compared to
sham operation group (P < 0.05, respectively) in the 1-, 2-, and
4-week subgroups
bindicated that TF antigen and activity in the 4-week subgroup compared to
1-week subgroup (P >0.05, respectively) and compared to 2-week subgroup
(P >0.05, respectively) in the experimental group
cindicated that TF antigen and activity in the 2-week subgroup compared to
1-week subgroup (P >0.05, respectively) in the experimental group
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ratio (r = 0.972, P < 0.05). Beclin-1 and LC3B protein ex-
pression had a negative correlation with the WA/TA ratio
(r = -0.963, P < 0.05, r = -0.965, P < 0.05, respectively).
Pearson correlations coefficient (r) for TF, Beclin-1, and
LC3B protein expression in the pulmonary artery
TF protein expression in the pulmonary artery had a
negative correlation with both Beclin-1 and LC3B pro-
tein expression (r = -0.995, P <0.05, r = -0972, P < 0.05,
respectively; Table 4).
Discussion
A rat model of CTEPH
Previously approved PTE animal models have been useful
for understanding the pathogenesis and pathophysio-
logical changes of PTE, evaluating methods for diagnosis,
and providing new therapeutic approaches [2]. However,
since the pathogenesis and pathological changes of
CTEPH are complex, it is difficult to mimic the patho-
physiological changes in an animal model [10]. Since the
1990s, several attempts to develop CTEPH animal models
using microspheres or polidocanol foam have failed be-
cause of the high fibrinolysis potential of pulmonary endo-
thelial cells and the adaptive capabilities of the pulmonary
circulation [3, 11, 12]. However, an animal model of PTE
has been developed using the injection of an exogenous
thrombus from the femoral vein into the pulmonary artery
to mimic the pathophysiology of deep vein thrombosis
(DVT)-PTE [13]. Li et al. [14] have established a rat model
of CTEPH by injecting thrombi twice in 2 weeks through
the jugular vein.
In our study, we found that the mPAP gradually in-
creased in the 1-, 2-, and 4-week subgroups in the experi-
mental group, indicating that we have successfully
established a rat model of CTEPH by repeated injection of
autologous blood clots into the pulmonary artery. Our pre-
liminary experiments demonstrated almost complete fibrin-
olysis of autologous clot PTE within 5 days, similar to the
results for the minimally-invasive autologous clot PTE
model developed in Sprague–Dawley and Copenhagen rats
by Runyon et al. [15]. In order to extend the persistence
time of autologous blood clots in animals and trigger the
vasculopathy in the pulmonary artery, we repeated the in-
jection of autologous clots into the pulmonary artery after
4 days. Concomitantly, because of the robust fibrinolytic
system in the rats, TXA was injected in order to inhibit en-
dogenous fibrinolysis in the animals [4, 15]. The positions
of the rats were changed so that more blood clots could be
injected into the pulmonary artery, for example, from su-
pine position to prone position. The risk factors for DVT,
which include hypercoagulability, vessel wall injury, and
blood stasis, were proposed by Virchow over 150 years ago
[16]. Therefore, we also restrained rat activity prior to- and
post operation to mimic the pathophysiological changes of
blood stasis. In this study, we have demonstrated that
reddish-brown thrombi adhere to the lower lobar artery
Fig. 3 TF antigen expression in rat plasma from different groups. Note: S = sham operation group, E = experimental group. a 1-week subgroup;
b 2-week subgroup; c 4-week subgroup. * indicated that TF antigen expression and activity in the plasma of experimental group compared to
sham operation group (P < 0.05, respectively) in the 1-, 2-, and 4-week subgroups. # indicated that the TF antigen expression and activity in the plasma
of 4-week subgroup compared to 1-week subgroup (P >0.05, respectively) and 2-week subgroup (P >0.05, respectively) in the experimental group. &
indicated that the TF antigen expression and activity in the plasma of 2-week subgroup compared to 1-week subgroup (P >0.05, respectively) in the
experimental group
Deng et al. Respiratory Research  (2016) 17:65 Page 6 of 11
wall, the presence of tissue on the surface of the thrombi,
invasive growth into the thrombi, pulmonary artery endo-
thelial cells (PAECs) are closely connected with the
thrombus in the pulmonary artery, and that the thickened
intima is present in the distal pulmonary artery. These find-
ings concur with our previous study showing that path-
ology is altered following PTE [17]. In addition, the WA/
TA ratio gradually increased in the present study and there
was a positive correlation between the WA/TA ratio and
the mPAP. Therefore, the development of chronic pulmon-
ary hypertension is associated with significant vascular re-
modeling due to the extensively thickened intima in the
distal pulmonary artery caused by repeated embolization in
the proximal pulmonary artery.
Expression of TF and autophagy in the CTEPH model
TF expression in rats following repeated embolization
TF is a transmembrane glycoprotein that plays an essen-
tial role in triggering blood coagulation [18]. TF can be
produced in endothelial cells and monocytes, however,
blood mononuclear cells and endothelial cells do not ex-
press TF under normal circumstances [19–21]. Experi-
mental studies in mice have revealed that circulating
mononuclear phagocytes carrying TF contribute to
thrombus formation [22]. In PTE patients, the plasma
levels of TF produced by leukocytes were increased and
played an important role in the pathogenesis of PTE [18].
A previous study has shown that monocyte and plasma
TF levels were significantly increased in subjects with
DVT compared to controls and monocyte TF levels corre-
lated with plasma TF levels [23]. Therefore, in this model,
the increased plasma TF following repeated embolization
may be produced by monocytes. In addition, a previous
study has shown that TF activity levels were elevated in
patients with symptoms of PE [22].
In our study, plasma TF concentration and activity in
the 1-week, 2-week, and 4-week subgroups in the experi-
mental group increased significantly compared with the
Fig. 4 Immunohistochemical analysis of TF, Beclin-1 and LC3B antigen expression in the pulmonary artery. Note: TF antigen was expressed in the
pulmonary artery intima of rats in both the sham operation and experimental group. TF antigen expression was low in the pulmonary arterial
intima of the sham operation group (a). However, TF antigen expression was increased in the experimental group in 1-, 2-, and 4-week subgroups
(b, c, d, respectively). Beclin-1 and LC3B antigen were expressed in the pulmonary artery of rats in both the sham operation and experimental
groups. The expression of Beclin-1 (f, g, h) and LC3B (j, k, l) antigen in the experimental groups was lower than in the sham operation group
(e, i), especially in the pulmonary arterial intima
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sham operation group, which may contribute to secondary
thrombosis. In addition, there was a positive correlation
between TF activity and WA/TA ratio. Therefore, in-
creased TF activity may lead to gradual degenerative
changes in pathology and increased mPAP following re-
peated embolization.
Under normal conditions, TF antigen expression was
concentrated mainly in the pulmonary artery adventitia and
rarely in the intima. Vessel wall TF expression can be ele-
vated when intact endothelial cells are impaired; TF expres-
sion may originate from subendothelial cells exposed at
sites of denuding injury and leukocytes adherent to the
vessel wall [24]. Our immunohistochemistry results showed
that the expression of TF antigen is increased in the intima.
Concomitantly, the expression of TF mRNA and protein
were significantly elevated in the pulmonary artery of the
1-, 2-, and 4-week subgroups in the experimental group,
similar to the results of a previous study demonstrating that
TF expression is significantly increased in a rabbit acute
pulmonary embolism model [7]. In summary, we have
demonstrated that the increase in TF expression may result
in the formation and maintenance of thrombi. However,
there were no significant differences between the 1-, 2-,
and 4-week subgroups in the experimental group. It is
possible that TF expression reach its maximal level due
to leukocytes in the injured endothelial cells.
Table 3 Tissue factor, Beclin-1, and microtubule-associated protein
1 light chain mRNA expression in the pulmonary artery (x ± SD)
Parameters Subgroup (each n = 15) Sham Experimental group
TF/β-actin
1-week 0.35 ± 0.15 0.85 ± 0.23a
2-week 0.39 ± 0.18 0.96 ± 0.26ac
4-week 0.41 ± 0.21 0.84 ± 0.22ab
Beclin-1/β-actin
1-week 0.88 ± 0.31 0.43 ± 0.20a
2-week 0.81 ± 0.28 0.38 ± 0.14ac
4-week 0.94 ± 0.37 0.51 ± 0.29ab
LC3B/β-actin
1-week 0.98 ± 0.28 0.51 ± 0.19a
2-week 0.89 ± 0.21 0.45 ± 0.15ac
4-week 0.96 ± 0.24 0.49 ± 0.18ab
TF tissue factor, LC3 microtubule-associated protein 1 light chain, LC3B a
phosphatidylethanolamine conjugated form of LC3
aindicated that TF, Beclin-1 and LC3B in the experimental group compared to
sham operation group (P < 0.05, respectively) in the 1-, 2-, and
4-week subgroups
bindicated that the TF, Beclin-1 and LC3B in the 4-week subgroup compared
to 1-week subgroup (P >0.05, respectively) and compared to 2-week subgroup
(P >0.05, respectively) in the experimental group
cindicated that the TF, Beclin-1 and LC3B in the 2-week subgroup compared to
1-week subgroup (P >0.05, respectively) in the experimental group
Fig. 5 TF, Beclin-1, and LC3B mRNA expression in the pulmonary artery. Note: S = sham operation group, E = experimental group. a Sham operation
group; b 1-week subgroup in experimental group; c 2-week subgroup in experimental group; d 4-week subgroup in experimental group. TF, Beclin-1, and
LC3B mRNA were expressed in the pulmonary artery of rats in both the sham operation and experimental groups. TF mRNA expression in
the experimental groups was increased compared to the sham operation group (a). In contrast, the Beclin-1 and LC3B mRNA expression
was lower in the experimental groups than in the sham operation group (b, c). * indicated that TF, Beclin-1, and LC3B mRNA expression of
experimental group compared to sham operation group (P < 0.05, respectively) in the 1-, 2-, and 4-week subgroups. # indicated that the TF,
Beclin-1, and LC3B mRNA expression of 4-week subgroup compared to 1-week subgroup (P >0.05, respectively) and 2-week subgroup
(P >0.05, respectively) in the experimental group. & indicated that the TF, Beclin-1, and LC3B mRNA expression of 2-week subgroup
compared to 1-week subgroup (P >0.05, respectively) in the experimental group
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Therefore, TF may play an important role in the devel-
opment of PTE and CTEPH, especially by contributing
to vascular remodeling and PH.
Beclin-1 and LC3B expression in the pulmonary artery
following repeated embolization
The proteins Beclin-1 and LC3B are recruited to autophago-
somal membranes during the formation of autophagosomes.
Once the autophagosomes fuse with lysosomes to form
autophagolysosomes, Beclin-1 and LC3B present on the
inner autophagosomal membrane are degraded by the lyso-
somal proteases [25]. Subsequent studies identified LC3 and
Beclin-1 as essential markers for autophagy [26]. Impaired
autophagic flux is characterized by accumulated autophago-
somes and reduced formation of autophagolysosomes [27].
Therefore, the decreased Beclin-1 and LC3B protein levels
indicate that more Beclin-1 and LC3B protein were de-
graded because of more autophagolysosomes were being
formed or less autophagosomes were being formed due to
impaired autophagic flux. Our results showed that the
Fig. 6 Western blot analysis of TF, Beclin-1, and LC3B protein expression in the pulmonary artery. Note: S = sham operation group, E = experimental group.
a Sham operation group; b 1-week subgroup in experimental group; c 2-week subgroup in experimental group; d: 4-week subgroup in experimental
group. TF, Beclin-1, and LC3B protein were expressed in the pulmonary artery of rats in both the sham operation and experimental groups (a). TF protein
expression in the experimental groups was increased compared to the sham operation group (b). In contrast, the Beclin-1 and LC3B protein expression
was lower in the experimental groups than in the sham operation group (c, d). * indicated that TF, Beclin-1, and LC3B protein expression of experimental
group compared to sham operation group (P< 0.05, respectively) in the 1-, 2-, and 4-week subgroups. # indicated that the TF, Beclin-1, and LC3B protein
expression of 4-week subgroup compared to 1-week subgroup (P >0.05, respectively) and 2-week subgroup (P >0.05, respectively) in the experimental
group. & indicated that the TF, Beclin-1, and LC3B protein expression of 2-week subgroup compared to 1-week subgroup (P >0.05, respectively) in the
experimental group
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expression of Beclin-1 and LC3B were much lower in the
pulmonary artery of the 1-, 2-, and 4-week subgroups in the
experimental group than that in the sham group, especially
in the pulmonary arterial intima. These findings suggest that
there may be a defective autophagic process in the pulmon-
ary arterial intima in the rat model of CTEPH.
Nguyen et al. [28] found that deletion of Beclin-1 re-
duced the plasminogen- induced autophagy and acceler-
ated apoptosis, indicating that interruption of autophagy
may give rise to an antiangiogenic effect on the endothe-
lial cells. Moreover, Beclin-1 may form complexes with
apoptotic protein Bcl-2 and thus lack of Beclin-1 may
accelerate caspase dependent apoptosis [29]. In contrast,
Lee et al. showed that expression of Beclin-1 in endothe-
lial cells of hemizygous mice resulted in increased prolifer-
ation, migration, and tube formation compared to the
wild-type cells [30]. These results suggest that inhibition
of autophagy may promote a switch to apoptosis. Many
researchers believe that apoptosis-resistance may result
from an initial wave of endothelial cell apoptosis triggered
by environmental stress that leads to hyperproliferative
endothelial cells [31]. Therefore, the reduced expression of
Beclin-1 demonstrated in our study may promote a switch
to apoptosis, leading to apoptosis-resistant and hyperproli-
ferative endothelial cells. A previous study has shown that
deletion of LC3B increases the stabilization of hypoxia-
inducible factor-a and the production of reactive oxygen
species and contributes to endothelial cell proliferation
[32]. It is possible that the autophagic protein LC3B exerts
a protective function during the pathogenesis of CTEPH
through the regulation of endothelial cell proliferation.
Therefore, defective autophagic processes in the pulmon-
ary artery intima may result in decreased expression of
Beclin-1 and LC3B and ultimately lead to PAEC prolifera-
tion in this CTEPH model. Previous findings support the
hypothesis that autophagy plays a critical role in vascular
remodeling by regulating smooth muscle cell phenotype
transitions [33]. In the present study, Beclin-1 protein ex-
pression in the pulmonary artery had a negative correlation
with the WA/TA ratio. LC3B protein expression also had a
negative correlation with the WA/TA ratio. These findings
suggest there may be a closed link between autophagy and
pulmonary vascular remodeling in CTEPH.
Correlation between TF, Beclin-1, and LC3B expression in
the pulmonary artery
Under a number of pathological conditions, TF can upregu-
late the expression of vascular endothelial growth factor
through the mitogen-activated protein kinase (MAPK) sig-
nal transduction pathway and thus promote vascular re-
modeling including endothelial cell proliferation and
angiogenesis [34]. A recent study found that forkhead box
transcription factor O-1 (FoxO1), a downstream signal of
MAPK, could participate in regulating the endothelial cell
autophagy [35]. Therefore, TF may regulate changes in au-
tophagy capacity by transforming the activity of the autoph-
agic upstream MAPK signal. Our study showed that TF
protein expression in the pulmonary artery had a negative
correlation with Beclin-1 and LC3B expression. Increased
TF expression may reduce the level of autophagic capacity
by regulating the activity of MAPK. Further studies are re-
quired to elucidate the underlying molecular mechanism.
Study limitations
Although the process of CTEPH was successfully mim-
icked in this study, some flaws distinguish between our
model and clinical CTEPH patients. While mPAP grad-
ually increased in our model following repeated
embolization, the severity of elevated pulmonary artery
pressure was notably different from that of CTEPH pa-
tients. Thrombolysis was still apparent in our model; other
procedures such as heating the autologous blood clots in a
70 °C water bath for 10 min prior to injection may be re-
quired to inhibit thrombi lysis [36]. The intima of rat pul-
monary artery was difficult to separate and the further
research will be mainly concentrated in the intima in our
model to imitate the research of endarterectomized tissues
from patients with CTEPH. In addition, elucidation of the
complex nature of the mechanisms of vascular remodeling
in clinical cases with CTEPH require further study.
Table 4 Pearson correlation coefficient (r) for the WA/TA ratio, mPAP, TF activity and TF, Beclin-1, and LC3 protein expression in the
pulmonary artery
WA/TA ratio mPAP TF protein
mPAP 0.955 (p = 0.045) – –
TF activity 0.972 (p = 0.028) 0.914 (p = 0.086) –
TF protein 0.894 (p = 0.110) 0.738 (p = 0.260) –
Beclin-1 protein −0.963 (p = 0.037) −0.862 (p = 0.140) −0. 995 (p = 0.005)
LC3B protein −0.965 (p = 0.035) −0.847 (p = 0.150) −0.972 (p = 0.028)
mPAP mean pulmonary arterial pressure, WA/TA vessel wall area/total area, TF tissue factor, LC3microtubule-associated protein 1 light chain, LC3B a phosphatidylethanolamine
conjugated form of LC3
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Conclusion
A rat model of CTEPH can be established by repeatedly
introducing autologous blood clots into the pulmonary
artery with injecting TXA. The WA/TA ratio and mPAP
were significantly increased in this rat CTEPH model.
TF expression was increased and Beclin-1 and LC3B ex-
pression was decreased in this rat CTEPH model. TF
and autophagy may play a key role during CTEPH
pathogenesis, especially in vascular remodeling. How-
ever, the detailed mechanisms underlying these pro-
cesses warrant further investigation.
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